This information is intended for US healthcare professionals For Patients

medical information

Search information about vibegron

Are you interested in learning about vibegron for the treatment of overactive bladder (OAB)? To continue, please complete all required (*) fields below.

I understand that the information collected pertaining to me will be used in accordance with Urovant Sciences' Privacy Statement. By submitting this form, I agree that any information I request is unsolicited.*

Related Information

Report Adverse Events

833-UROVANT (Option 1)

Report Product Complaints

833-UROVANT (Option 1)

Tell us what interests you

How interested are you in learning more about the following topics?

The role of β3-adrenoreceptor agonists in treating patients with OAB
Comorbidities among patients with OAB
Reducing the potential risk of drug-drug interactions
Clinical burden of OAB
Economic burden of OAB


We’ve received your completed survey. Thanks for participating.


Thank You.

We’ve received your inquiry. Thank you for contacting Urovant Sciences Medical Affairs. We will contact you shortly.


Take Survey

Welcome to
Urovant Sciences Medical Affairs

This site is intended as an educational resource for U.S. healthcare providers. The content may include information about products or potential uses that have not been approved by the U.S. Food and Drug Administration.

This information is not intended to be promotional or deliver medical advice.

Choose an option:

I’m a U.S. healthcare professional I’m a U.S. patient or caregiver